天然多糖的潜力用于卵巢癌治疗
Miaomiao Xiao1, Siwen Chen2, Yaochen Yang3
1Research Center for Biomedical Materials, Engineering Research Center of Ministry of Education for Minimally Invasive Gastrointestinal Endoscopic Techniques, Shengjing Hospital of China Medical University, Shenyang 11004, China.
Carbohydrate polymers
|November 20, 2024
概括
天然多糖类,如氨酸和奇托,为卵巢癌治疗提供了新的希望. 这些生物活性聚合物表现出抗瘤特性,可用于先进的药物输送系统,以提高治疗效率.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 聚合物化学 聚合物化学
背景情况:
- 卵巢癌是一种致命的疾病,具有具有挑战性的治疗结果.
- 目前的治疗方法 (手术,化疗) 面临诸如耐药性和严重副作用等局限性.
- 创新药物输送对于提高卵巢癌治疗疗效至关重要.
研究的目的:
- 在卵巢癌中审查天然多糖的治疗应用.
- 讨论这些聚合物的内在抗瘤特性.
- 总结它们在卵巢癌的先进药物输送系统中的作用.
主要方法:
- 对天然多糖的文献综述 (氨酸,奇托,酸盐,纤维素).
- 对抗瘤活动和药物输送系统应用的分析.
- 对基于多糖的卵巢癌治疗方法的研究结果的综合.
主要成果:
- 自然的多糖体具有显著的抗瘤特性.
- 这些聚合物在开发新型药物输送系统方面是有效的.
- 氨酸,奇托,酸盐和纤维素在卵巢癌治疗中表现有前途.
结论:
- 天然多糖因其生物活性而在卵巢癌治疗中具有价值.
- 它们可以增强化疗和放射治疗的疗效.
- 基于多糖的输送系统是克服治疗挑战的有希望的策略.
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Hormones Regulating Blood Glucose
7.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.5K
Hypoglycemia and Glucagon
1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K


